133 related articles for article (PubMed ID: 19256500)
1. Antihypertensive drug valsartan in solution and at the AT1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking, and molecular dynamics simulations.
Potamitis C; Zervou M; Katsiaras V; Zoumpoulakis P; Durdagi S; Papadopoulos MG; Hayes JM; Grdadolnik SG; Kyrikou I; Argyropoulos D; Vatougia G; Mavromoustakos T
J Chem Inf Model; 2009 Mar; 49(3):726-39. PubMed ID: 19256500
[TBL] [Abstract][Full Text] [Related]
2. Dynamic NMR study and theoretical calculations on the conformational exchange of valsartan and related compounds.
Li F; Zhang H; Jiang L; Zhang W; Nie J; Feng Y; Yang M; Liu M
Magn Reson Chem; 2007 Nov; 45(11):929-36. PubMed ID: 17876862
[TBL] [Abstract][Full Text] [Related]
3. Dominant conformation of valsartan in sodium dodecyl sulfate micelle environment.
Li F; Wang L; Xiao N; Yang M; Jiang L; Liu M
J Phys Chem B; 2010 Mar; 114(8):2719-27. PubMed ID: 20131883
[TBL] [Abstract][Full Text] [Related]
4. Understanding the interaction between valsartan and detergents by NMR techniques and molecular dynamics simulation.
Cao C; Mao J; Li F; Yang M; He H; Jiang L; Liu M
J Phys Chem B; 2012 Jun; 116(25):7470-8. PubMed ID: 22708715
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the AT1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers.
Potamitis C; Chatzigeorgiou P; Siapi E; Viras K; Mavromoustakos T; Hodzic A; Pabst G; Cacho-Nerin F; Laggner P; Rappolt M
Biochim Biophys Acta; 2011 Jun; 1808(6):1753-63. PubMed ID: 21315062
[TBL] [Abstract][Full Text] [Related]
6. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
J Med Chem; 1999 May; 42(10):1714-22. PubMed ID: 10346924
[TBL] [Abstract][Full Text] [Related]
7. Thermal behavior and phase identification of Valsartan by standard and temperature-modulated differential scanning calorimetry.
Skotnicki M; Gaweł A; Cebe P; Pyda M
Drug Dev Ind Pharm; 2013 Oct; 39(10):1508-14. PubMed ID: 22803969
[TBL] [Abstract][Full Text] [Related]
8. Valsartan.
Ardiana F; Suciati ; Indrayanto G
Profiles Drug Subst Excip Relat Methodol; 2015; 40():431-93. PubMed ID: 26051690
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers.
Fotakis C; Megariotis G; Christodouleas D; Kritsi E; Zoumpoulakis P; Ntountaniotis D; Zervou M; Potamitis C; Hodzic A; Pabst G; Rappolt M; Mali G; Baldus J; Glaubitz C; Papadopoulos MG; Afantitis A; Melagraki G; Mavromoustakos T
Biochim Biophys Acta; 2012 Dec; 1818(12):3107-20. PubMed ID: 22906712
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
[TBL] [Abstract][Full Text] [Related]
11. Solubilization of valsartan by aqueous glycerol, polyethylene glycol and micellar solutions.
Mbah CJ
Pharmazie; 2006 Apr; 61(4):322-4. PubMed ID: 16649547
[TBL] [Abstract][Full Text] [Related]
12. Trans and Cis Conformations of the Antihypertensive Drug Valsartan Respectively Lock the Inactive and Active-like States of Angiotensin II Type 1 Receptor: A Molecular Dynamics Study.
Wang L; Yan F
J Chem Inf Model; 2018 Oct; 58(10):2123-2130. PubMed ID: 30212210
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical properties of valsartan and the effect of ethyl alcohol, propylene glycol and pH on its solubility.
Mbah CJ
Pharmazie; 2005 Nov; 60(11):849-50. PubMed ID: 16320948
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular hydrogen bonding in disubstituted ethanes: general considerations and methodology in quantum mechanical calculations of the conformational equilibria of succinamate monoanion.
Rudner MS; Kent DR; Goddard WA; Roberts JD
J Phys Chem A; 2005 Oct; 109(40):9083-8. PubMed ID: 16332015
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
16. Insights into the molecular basis of action of the AT1 antagonist losartan using a combined NMR spectroscopy and computational approach.
Zervou M; Cournia Z; Potamitis C; Patargias G; Durdagi S; Grdadolnik SG; Mavromoustakos T
Biochim Biophys Acta; 2014 Mar; 1838(3):1031-46. PubMed ID: 24374319
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of antimicrobial peptides into membranes: a combined liquid-state NMR and molecular dynamics study of alamethicin in DMPC/DHPC bicelles.
Dittmer J; Thøgersen L; Underhaug J; Bertelsen K; Vosegaard T; Pedersen JM; Schiøtt B; Tajkhorshid E; Skrydstrup T; Nielsen NC
J Phys Chem B; 2009 May; 113(19):6928-37. PubMed ID: 19368399
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
Brath U; Akke M
J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
[TBL] [Abstract][Full Text] [Related]
19. Electrochemical behavior of valsartan and its determination in capsules.
Yan J; Wang W; Chen L; Chen S
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):205-9. PubMed ID: 18823761
[TBL] [Abstract][Full Text] [Related]
20. Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry.
Skotnicki M; Aguilar JA; Pyda M; Hodgkinson P
Pharm Res; 2015 Feb; 32(2):414-29. PubMed ID: 25115829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
